Martinez Juan, Ingram Nicola, Kapur Nikil, Jayne David G, Beales Paul A
School of Chemistry, University of Leeds, Leeds, West Yorkshire, United Kingdom.
Leeds Institute for Medical Research, University of Leeds, Leeds, West Yorkshire, United Kingdom.
Pain Rep. 2024 Oct 10;9(6):e1196. doi: 10.1097/PR9.0000000000001196. eCollection 2024 Dec.
Pain, a complex and debilitating condition, necessitates innovative therapeutic strategies to alleviate suffering and enhance patients' quality of life. Vesicular systems hold the potential to enhance precision of drug localisation and release, prolong the duration of therapeutic action and mitigate adverse events associated with long-term pharmacotherapy. This review critically assesses the current state-of-the-art in vesicle-based formulations (liposomes, polymersomes, ethosomes, and niosomes) for pain management applications. We highlight formulation engineering strategies used to optimise drug pharmacokinetics, present preclinical findings of experimental delivery systems, and discuss the clinical evidence for the benefits of clinically approved formulations. We present the challenges and outlook for future improvements in long-acting anaesthetic and analgesic formulation development.
疼痛是一种复杂且使人衰弱的病症,需要创新的治疗策略来减轻痛苦并提高患者的生活质量。囊泡系统有潜力提高药物定位和释放的精准度,延长治疗作用的持续时间,并减轻与长期药物治疗相关的不良事件。本综述批判性地评估了用于疼痛管理应用的基于囊泡的制剂(脂质体、聚合物囊泡、醇质体和非离子表面活性剂囊泡)的当前技术水平。我们强调了用于优化药物药代动力学的制剂工程策略,展示了实验性给药系统的临床前研究结果,并讨论了临床批准制剂益处的临床证据。我们提出了长效麻醉和镇痛制剂开发未来改进的挑战与展望。